Alexander Rosemury

A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.

J. Berlin, R. Wadlow, R. Newman, 2020, The oncologist.